Literature DB >> 30806746

Lipocalin-2 is dispensable in inflammation-induced sickness and depression-like behavior.

Elisabeth G Vichaya1, Phillip S Gross2, Darlene J Estrada2, Steve W Cole3, Aaron J Grossberg4, Scott E Evans5, Michael J Tuvim5, Burton F Dickey5, Robert Dantzer2.   

Abstract

RATIONALE: While the relationship between inflammation and depression is well-established, the molecular mechanisms mediating this relationship remain unclear. RNA sequencing analysis comparing brains of vehicle- and lipopolysaccharide-treated mice revealed LCN2 among the most dysregulated genes. As LCN2 is known to be an important regulator of the immune response to bacterial infection, we investigated its role in the behavioral response to lipopolysaccharide.
OBJECTIVE: To explore the role of LCN2 in modulating behavior following lipopolysaccharide administration using wild type (WT) and lcn2-/- mice.
METHODS: Using a within-subjects design, mice were treated with 0.33 mg/kg liposaccharide (LPS) and vehicle. Primary outcome measures included body weight, food consumption, voluntary wheel running, sucrose preference, and the tail suspension test. To evaluate the inflammatory response, 1 week later, mice were re-administered either vehicle or LPS and terminated at 6 h.
RESULTS: While lcn2-/- mice had increased baseline food consumption and body weight, they showed a pattern of reduced food consumption and weight loss similar to WT mice in response to LPS. WT and lcn2-/- mice both recovered voluntary activity on the fourth day following LPS. LPS induced equivalent reductions in sucrose preference and TST immobility in the WT and lcn2-/- mice. Finally, there were no significant effects of genotype on inflammatory markers.
CONCLUSIONS: Our data demonstrate that lcn2 is dispensable for sterile inflammation-induced sickness and depression-like behavior. Specifically, lcn2-/- mice displayed sickness and immobility in the tail suspension test comparable to that of WT mice both in terms of intensity and duration.

Entities:  

Keywords:  Depression; Inflammation; Innate immunity; Lipocalin-2; Lipopolysaccharide; Sickness behavior

Mesh:

Substances:

Year:  2019        PMID: 30806746      PMCID: PMC6710168          DOI: 10.1007/s00213-019-05190-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  49 in total

Review 1.  Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?

Authors:  R Dantzer; J P Konsman; R M Bluthé; K W Kelley
Journal:  Auton Neurosci       Date:  2000-12-20       Impact factor: 3.145

2.  Physiology: Bone-derived hormone suppresses appetite.

Authors:  Richard D Palmiter
Journal:  Nature       Date:  2017-03-08       Impact factor: 49.962

Review 3.  The posterior parietal cortex as integrative hub for whisker sensorimotor information.

Authors:  Hemanth Mohan; Roel de Haan; Huibert D Mansvelder; Christiaan P J de Kock
Journal:  Neuroscience       Date:  2017-06-19       Impact factor: 3.590

4.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

5.  The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages.

Authors:  Jinhui Zhang; Yingjie Wu; Yuanyuan Zhang; Derek Leroith; David A Bernlohr; Xiaoli Chen
Journal:  Mol Endocrinol       Date:  2008-02-21

6.  NGAL and other markers of inflammation as competitive or complementary markers for depressive symptom dimensions in heart failure.

Authors:  Petrus J W Naudé; Paula M C Mommersteeg; Leonie Gouweleeuw; Ulrich L M Eisel; Johan Denollet; Lambertus W J J M Westerhuis; Regien G Schoemaker
Journal:  World J Biol Psychiatry       Date:  2015-07-27       Impact factor: 4.132

7.  Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior.

Authors:  Maïté Moreau; Caroline André; Jason C O'Connor; Sara A Dumich; Jeffrey A Woods; Keith W Kelley; Robert Dantzer; Jacques Lestage; Nathalie Castanon
Journal:  Brain Behav Immun       Date:  2008-05-13       Impact factor: 7.217

8.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

Authors:  Charles L Raison; Robin E Rutherford; Bobbi J Woolwine; Chen Shuo; Pamela Schettler; Daniel F Drake; Ebrahim Haroon; Andrew H Miller
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

9.  Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.

Authors:  Rita Haapakoski; Julia Mathieu; Klaus P Ebmeier; Harri Alenius; Mika Kivimäki
Journal:  Brain Behav Immun       Date:  2015-06-09       Impact factor: 7.217

Review 10.  Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis.

Authors:  S P Leighton; L Nerurkar; R Krishnadas; C Johnman; G J Graham; J Cavanagh
Journal:  Mol Psychiatry       Date:  2017-11-14       Impact factor: 15.992

View more
  5 in total

1.  Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy.

Authors:  Hui Wang; Hui Lou; Yongrong Li; Fengtao Ji; Wei Chen; Qianyi Lu; Guoxu Xu
Journal:  BMC Ophthalmol       Date:  2020-06-30       Impact factor: 2.209

2.  Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia.

Authors:  Brennan Olson; Xinxia Zhu; Mason A Norgard; Peter R Levasseur; John T Butler; Abigail Buenafe; Kevin G Burfeind; Katherine A Michaelis; Katherine R Pelz; Heike Mendez; Jared Edwards; Stephanie M Krasnow; Aaron J Grossberg; Daniel L Marks
Journal:  Nat Commun       Date:  2021-04-06       Impact factor: 14.919

3.  Elevated levels of neutrophil gelatinase-associated lipocalin among OCD patients: an exploratory study.

Authors:  Fernanda Marques; Pedro Morgado; Catarina Raposo-Lima; Inês Miguel Pereira
Journal:  BMC Psychiatry       Date:  2021-05-26       Impact factor: 3.630

Review 4.  Lipocalin-2 and Cerebral Stroke.

Authors:  Chao Luo; Shuai Zhou; Shi Yin; Lipeng Jian; Pengren Luo; Jigeng Dong; Erheng Liu
Journal:  Front Mol Neurosci       Date:  2022-04-12       Impact factor: 6.261

5.  Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder.

Authors:  Jingjing Zhou; Jia Zhou; Zuoli Sun; Lei Feng; Xuequan Zhu; Jian Yang; Gang Wang
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.